KLOW
80mg
⚠️ Not for human consumption. Research purposes only.
Description
KLOW is an 80mg research blend combining BPC-157 (10mg), TB500 (10mg), KPV (10mg), and GHK-Cu (50mg). This four-compound formulation is designed for preclinical and in vitro studies exploring multi-pathway tissue repair, inflammatory cytokine modulation, and extracellular matrix signaling. Each peptide has been independently characterized in peer-reviewed literature, and this blend allows researchers to investigate their synergistic interactions under controlled experimental conditions.
Key Areas of Study
- Multi-pathway tissue repair modeling
- inflammatory cytokine modulation research
- extracellular matrix signaling studies
- synergistic peptide interaction analysis
Mechanisms Being Evaluated
BPC-157 has been observed to promote angiogenesis and modulate nitric oxide pathways in preclinical models. TB500 upregulates actin expression, facilitating cell migration and proliferation in tissue culture. KPV, an alpha-MSH-derived tripeptide, has been studied for its role in modulating NF-κB inflammatory signaling cascades. GHK-Cu acts as a copper-binding tripeptide investigated for its involvement in collagen synthesis signaling and antioxidant enzyme activation.
Commonly Researched Uses
Preclinical tissue repair research, inflammatory pathway modulation studies, multi-peptide synergy investigations, extracellular matrix remodeling and cytokine signaling analysis